Why the study?
Does coronary care unit admission and type of diabetes therapy affect mortality in diabetic patients with acute myocardial infarction?
Does coronary care unit admission and type of diabetes therapy affect mortality in diabetic patients with acute myocardial infarction?
Answers are grounded in this paper and cite their sources.
Diabetic patients with acute myocardial infarction face high short- and long-term mortality, with outcomes and benefit from coronary care unit admission varying based on their prior diabetes treatment regimen.
The hospital mortality of acute myocardial infarction amongst 285 known diabetics treated in the last decade was 39.7 per cent at one month and had increased to 51 per cent at 12 months. Treatment in a coronary care unit during the acute stage had little effect on the mortality amongst patients on insulin, but was beneficial for patients whose diabetes had been controlled by oral hypoglycaemic drugs. Female patients on oral hypoglycaemic drugs had the highest mortality. When considering age, duration of diabetes and presence of retinopathy, acute myocardial infarction in diabetics controlled on oral therapy appeared to have a worse outcome than in patients on insulin. Independently of whether patients were on insulin or on oral hypoglycaemic drugs 12 months after the acute episode, only about half of them were still alive.
No takes yet. Share an insight, caveat, or question.
Soler et al. (1975) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: